[1] |
LU Renquan, LIU Guangyu, YANG Wentao, GUO Lin, GUAN Ming, SHAO Zhimin, XU Dazhi, NI Ming, TANG Feng, WANG Chaofu, LOU Jiatao, SUN Fenyong, XING Jinliang, PAN Yueyin.
Application consensus of peripheral blood HER2 gene amplification detection (digital PCR) in anti-HER2 therapy
[J]. China Oncology, 2022, 32(1): 90-96.
|
[2] |
ZHANG Xuecheng , GUAN Xiaohui .
Circ_0007142 accelerates epithelial-mesenchymal transition and invasion of gastric cancer cells through sponging miR-647 and regulating CCR8 gene
[J]. China Oncology, 2021, 31(8): 714-724.
|
[3] |
ZHU Yihui, LI Ting, HU Xichun.
Clinical research progress and prospect of trastuzumab deruxtecan
[J]. China Oncology, 2021, 31(8): 754-761.
|
[4] |
DING Gaofeng, GUO Leiming, LU Yufei.
The relationship between expressions of HER2 and BRCA1 and radiotherapy sensitivity in breast cancer patients
[J]. China Oncology, 2021, 31(7): 589-595.
|
[5] |
CAO Dalong, ZHU Wenkai, SHI Guohai, ZHANG Hailiang, WANG Ziliang, YE Dingwei.
The influence of PRUNE2 gene point mutation on proliferation, apoptosis, invasion and migration of prostate cancer DU145 cells
[J]. China Oncology, 2021, 31(6): 441-446.
|
[6] |
HU Yaqiong , BAI Jun , CHEN Lin , CHEN Xinlu , ZHANG Liping , ZHOU Dandan , WANG Yu , YIN Chonggao , LI Hongli , LIU Yuqing .
miR-625-5p promotes proliferation and invasion of lung adenocarcinoma by targeting PRKACA
[J]. China Oncology, 2021, 31(6): 447-454.
|
[7] |
CHEN Jie, WANG Yan, ZHANG Weimin, ZHAO Di, ZHANG Lingyuan, ZHAN Qimin.
Hypoxia induces expression of IL-7 in esophageal squamous cell carcinoma to promote tumor progression
[J]. China Oncology, 2021, 31(5): 361-367.
|
[8] |
HUA Qing, SHEN Xuefang, XU Pingbo .
Effect of KLK8 on apoptosis of colorectal cancer cells by regulating EGF and its mechanism
[J]. China Oncology, 2021, 31(5): 383-389.
|
[9] |
LIU Min , CHEN Tianliang , GUO Juan , YI Xue , GAO Hongquan , WU Jiacui , WANG Yuxiao .
Protein kinase Cβ Ⅱ promotes invasion of hepatocellular carcinoma by modulating autocrine of IL-6
[J]. China Oncology, 2021, 31(4): 268-276.
|
[10] |
QIAO Tingting , GE Shujing , LUO Yuan , LU Chengrong , DUAN Lianning .
Mechanism of inhibition of epithelial-to-mesenchymal transition by phosphorylated H2AX in lung cancer cells
[J]. China Oncology, 2021, 31(4): 277-284.
|
[11] |
WANG Chunjian , NIE Gang , MAO Yan .
The role of TRIP6 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(3): 161-169.
|
[12] |
ZHANG Yanjun, LI Jianchang, JIA Xiuhong, TIAN Chunmei.
Effects of FGFR inhibitor BGJ398 on cell biological behavior and drug resistance of leukemia cells
[J]. China Oncology, 2021, 31(3): 176-181.
|
[13] |
GUO Ye , ZHANG Chenping .
Expert consensus on the treatment of recurrent/metastatic squamous cell carcinoma of the head and neck with anti-EGFR monoclonal antibody (2021 edition)
[J]. China Oncology, 2021, 31(12): 1220-1232.
|
[14] |
HE Guoyang , , CHEN Qingqing , DENG Meijing , WANG Gaoxiang , WANG Beixi , WANG Yongxia , , LI Wei , QIAN Xinlai , , ZHU Huifang , .
Effect of DIAPH3 on proliferation, migration and invasion of gastric cancer cells and its molecular mechanism
[J]. China Oncology, 2021, 31(12): 1174-1184.
|
[15] |
ZHANG Jinzhong , LI Yueqi , SHI Ke , YANG Liang , GUO Dan .
Expression and clinical significance of PLK4 gene in esophageal squamous cell carcinoma and its effect on cell proliferation, invasion and migration
[J]. China Oncology, 2021, 31(12): 1185-1193.
|